CardioDx®, Inc., is a cardiovascular genomic diagnostics company, that is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient.

Website CardioDx

www.cardiodx.com

Founded in 2004, CardioDx®, Inc., is a cardiovascular genomic diagnostics company located in Palo Alto, CA. As a pioneer in the field of cardiovascular genomic diagnostics, the company is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, cardiac arrhythmia, and heart failure, CardioDx is poised to expand patient access and improve healthcare quality and efficiency through the commercialization of genomic technologies.

Headquarter:
2500 Faber Place
Palo Alto, CA 94303

Back to portfolio